A Look at Phage Therapy One Hundred Years After the Bacteriophages Discovery


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

This overview discusses the literature data on the use of bacteriophages in the treatment of both acute and chronic infectious diseases caused by antibiotic-resistant pathogens. Traditionally, phage therapy is based on the use of naturally occurring phages for infection and lysis of bacteria at the site of infection. It has fundamental advantages over antibiotic therapy. At the same time, it has some disadvantages. Currently, the application of biotechnological methods, such as the development of the recombinant bacteriophages, makes it possible to eliminate the shortcomings of antimicrobial phage therapy and to expand its opportunities due to the use of lytic proteins of phages and their modified derivatives.

Sobre autores

T. Ilyina

Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation

Email: genes2007@yandex.ru
Rússia, Moscow, 123098

E. Tolordava

Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation

Email: genes2007@yandex.ru
Rússia, Moscow, 123098

Yu. Romanova

Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation; Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

Autor responsável pela correspondência
Email: genes2007@yandex.ru
Rússia, Moscow, 123098; Moscow, 119091

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Allerton Press, Inc., 2019